Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
That's Nice
Sort By
Newest First
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
(35)
1 / 2
Events
Pharma's Almanac & That's Nice at INTERPHEX 2025
Pharma's Almanac
PAO-04-24-PHEX-03
May 5, 2025
Oncology
From Chemo to Advanced Therapies: New Frontiers in Oncology
Serene Lee
Nice Insight
PAO-25-30-29
Apr 15, 2025
Gene Therapy
Gene Therapy at 30: Milestones, Setbacks, and a Path Forward
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-28
Apr 14, 2025
First-in-Class Drugs
Breaking New Ground: 30 Years of First-in-Class Drug Innovation
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-27
Apr 9, 2025
Supply Chain
Building Resilient Pharma Supply Chains in an Uncertain World
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-26
Mar 31, 2025
SUT
From Niche to Necessity: How Single-Use Transformed Biomanufacturing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-25
Mar 24, 2025
RNA
Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-24
Mar 21, 2025
Genomics
Genomics and the Next Era of Precision Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-23
Mar 20, 2025
Aging
Resetting the Biological Clock: OKSM and the Reversal of Aging
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-22
Mar 19, 2025
Global Trials
Clinical Trials Without Borders: The Evolution of Global Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-21
Mar 14, 2025
Space
The Final Frontier: Biomanufacturing in Space
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-20
Mar 13, 2025
Advocacy
From Patients to Partners: The Rising Power of Advocacy in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-19
Mar 13, 2025
DCTs
Accelerating Patient Access Through Decentralized Clinical Trials
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-18
Mar 12, 2025
Pandemic
Global Health at a Crossroads and the Future of Pandemic Preparedness
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-17
Mar 12, 2025
Biomarkers
The Biomarker Revolution in Medicine and Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-16
Mar 10, 2025
NTDs
Working Toward a Future Without Neglected Tropical Diseases
Serene Lee
Nice Insight
PAO-25-30-15
Mar 7, 2025
Diversity
Fighting for Diversity and Equity in Pharma and Biopharma
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-05
Mar 6, 2025
Collaboration
Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-14
Mar 3, 2025
HTS
The High-Throughput Screening Transformation in Modern Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-12
Mar 2, 2025
Accelerated Approval
30 Years of Accelerated Approvals: Fast-Tracking Innovation in Drug Development
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-07
Mar 2, 2025
1 / 2